TetraLogic Pharmaceuticals Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TLOG research report →
Price Chart
About the company
TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious diseases. The company's development pipeline features two key clinical-stage drug candidates: birinapant and SHAPE. Birinapant, a small molecule, functions as a Second Mitochondrial Activator of Caspases (SMAC) mimetic, promoting programmed cell death, or apoptosis, in compromised cells.
- CEO
- Yigong Shi
- IPO
- 2013
- Employees
- 29
- HQ
- Malvern, PA, US
Get TickerSpark's AI analysis on TLOG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $979
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.30
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -408.63%
- ROIC
- -74.54%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-187,993+0.0%
- Op Income
- $-44,991,026
- Net Income
- $-56,108,339-42.7%
- EPS
- $-2.37-34.7%
- OCF Growth
- -7.8%
- FCF Growth
- -6.3%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 4.06
- RSI (14)
- 49
- Avg Volume
- 379
No earnings-call transcripts are available for TLOG yet.
- Free Float
- 89.0%
- Shares Outstanding
- 24.47M
- Float Shares
- 21.77M
of shares held by institutions
19 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Sac Capital Advisors LP | 39.18K | ▲ 39.18K |
| Ubs AG | 4.06K | ▲ 1.16K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 15, 17 | Robins David C. | other | 0 |
| Nov 14, 16 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | other | 0 |
| Nov 14, 16 | WHITEBOX ADVISORS LLC | other | 3,018,260 |
| Nov 14, 16 | WHITEBOX ADVISORS LLC | other | 0 |
| Nov 14, 16 | WHITEBOX ADVISORS LLC | other | 0 |
| Nov 14, 16 | NOMURA SECURITIES INTERNATIONAL, INC. | other | 892,850 |
| Nov 14, 16 | NOMURA SECURITIES INTERNATIONAL, INC. | other | 0 |
| Nov 14, 16 | NOMURA SECURITIES INTERNATIONAL, INC. | other | 0 |
| Nov 14, 16 | Hudson Bay Capital Management LP | other | 279,367 |
| Nov 14, 16 | Hudson Bay Capital Management LP | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TLOG coverage
Recent articles, reports, and earnings notes.
No research on TLOG yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TLOG report →